AAP
BVS icon

Arax Advisory Partners’s Bioventus BVS Stock Holding History

Arax Advisory Partners’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.1K Buy
4,355
+4,150
+2,024% +$39.6K ﹤0.01% 3429
2026
Q1 		$1.87K Buy
205
+106
+107% +$889 ﹤0.01% 3125
2025
Q4 		$737 Sell
99
-2,711
-96% -$19.5K ﹤0.01% 3542
2025
Q3 		$18.8K Buy
+2,810
New +$19.5K ﹤0.01% 2288
2025
Q2 		– Sell
-67
Closed -$614 – 3060
2025
Q1 		$614 Buy
67
+9
+16% +$90 ﹤0.01% 2495
2024
Q4 		$609 Buy
+58
New +$686 ﹤0.01% 2289

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arax Advisory Partners's BVS Position: Q2 2026 in Review

Arax Advisory Partners increased its Bioventus (BVS) stake by 2,024% in Q2 2026, buying an estimated $39.6K and bringing the position to 4,355 shares worth $41.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3429.

Arax Advisory Partners first reported a position in BVS in Q4 2024 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Arax Advisory Partners held 4,355 shares of Bioventus worth $41.1K as of Q2 2026.
  • Arax Advisory Partners bought 4,150 Bioventus shares in Q2 2026, an estimated $39.6K.
  • Bioventus made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3429 holding.
  • Arax Advisory Partners first reported a position in Bioventus in Q4 2024 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.